Stockle - the stock oracle

RHINO BIOTECH Ltd

US:RBRXF
No current share price held for this company.

Past year: ▲ 0%(0.01c – 0.01c USD)

Market cap
—
Shares on issue
—
Story beats
17 since 2005
Last event
5 Sept 2023

Announcements, explained

Each one in plain English, with the numbers worked through for a shareholder.

24 Nov 2009substantial holder notice● Neutral

Gerald R. Tuskey disclosed a new substantial RHINO BIOTECH Ltd shareholding (14.39% of votes).

Discuss in chat

23 Nov 2009director interest notice● Neutral

RHINO BIOTECH Ltd director Gerald R Tuskey bought 2,500,000 shares on the open market at $0.05.

Discuss in chat

23 Nov 2009director interest notice● Neutral

RHINO BIOTECH Ltd President & CEO Nicholas W Baxter bought 2,500,000 shares on the open market at $0.05.

Discuss in chat

28 Oct 2009other material event▲ GoodMajor

The Scottish Court of Appeal on Oct 27, 2009 upheld the lower court's Dec 14, 2007 ruling that Eurasia is not liable to Commonwealth for losses from entering the SOCAR MOU. It also rejected Baxter's appeal, so the finding stands that he breached his fiduciary duty to Commonwealth, though the court found he did not act knowingly or dishonestly. The company says a damages award against it is remote and that a substantial award against Baxter will be difficult; it says it is continuing to pursue an Azerbaijan project. This largely resolves the company's side of the lawsuit, with Baxter's exposure partly outstanding.

Discuss in chat

24 Sept 2009director interest notice● Neutral

RHINO BIOTECH Ltd C.F.O. Graham Crabtree bought 5,000 shares on the open market at $0.01.

Discuss in chat

19 June 2009other material event▼ BadMajor

A June 2009 shareholder mailing (the filing text is truncated) calls 2008 a difficult year and says progress in Azerbaijan slowed. It reveals that SOCAR declined the company's requests to proceed to negotiate a PSA in early 2007, after the one-year MOU ended, and says continuing litigation since early 2006 and the financial crisis have blocked further progress, though the company is still trying to bring the project to fruition. It also gives notice of a July 14, 2009 annual meeting, covering director elections, auditor ratification (Peterson Sullivan LLP), a bylaw change to the quorum, and ratification of directors' acts since Jan 1, 2008. This continues the SOCAR and lawsuit threads and confirms the MOU did not lead to a PSA.

Discuss in chat

8 Apr 2009director interest notice● Neutral

Graham Crabtree became a RHINO BIOTECH Ltd Chief Financial Officer and company insider (initial ownership filing).

Discuss in chat

28 May 2008substantial holder notice● Neutral

Nicholas W. Baxter reported a RHINO BIOTECH Ltd shareholding of 1,073,364 shares (4.41% of votes) in a periodic institutional filing.

Discuss in chat

27 May 2008director interest notice● Neutral

RHINO BIOTECH Ltd President and CEO Nicholas W Baxter sold 2,000,000 shares at $0.05.

Discuss in chat

29 Apr 2008business combination● NeutralMajor

The company reports that it completed its move from Nevada to Anguilla, British West Indies, on December 31, 2007, resolving the long-running conversion thread. Its shares now trade on the OTC bulletin board under the symbol EUENF, which the filing says marks it as a foreign issuer, and it expects to file annual reports on Form 20-F from 2008. The filing says nothing about the SOCAR talks or the legal action. Shareholders keep their shares: the earlier plan kept them one-for-one, though this filing itself does not restate that.

Discuss in chat

5 Dec 2007securities registration● Neutral

RHINO BIOTECH Ltd amended an already-effective registration statement.

Discuss in chat

15 Nov 2007securities registration● Neutral

Eurasia Energy filed a prospectus/information statement for its plan to move its jurisdiction from Nevada to Anguilla, covering up to 24,315,135 shares. No stockholder vote was needed because a majority had already consented, and mailing to stockholders was due around December 7, 2007.

Discuss in chat

13 Nov 2007business combination● Neutral

Fourth amendment to the Anguilla move registration, still covering 24,315,135 shares. The visible text is only the cover, indemnification section, exhibit list (most exhibits marked as previously filed with Amendment No. 2 on October 15, 2007), undertakings and signatures by Baxter and Tuskey. It carries no new business or financial information in the text shown.

Discuss in chat

5 Nov 2007business combination● Neutral

Third amendment to the registration for moving the company's legal home from Nevada to Anguilla, still covering 24,315,135 shares at a $0.45 registration price, with the $0.32 closing price (October 4, 2007) unchanged from the prior version. The visible text repeats earlier points: the SOCAR MOU expired December 7, 2006, a development plan is done, and talks with SOCAR would only be re-established if the company wins the legal action against it. Shares stay one-for-one and dissenting holders keep appraisal rights. The excerpt is truncated, so what changed from Amendment No. 2 is not visible.

Discuss in chat

15 Oct 2007business combination● Neutral

Second amendment to the Anguilla move registration, with the same 24,315,135 shares covered and a $0.32 closing price (October 4, 2007). The visible text repeats the prior version's points: the SOCAR MOU expired December 7, 2006, a development plan is done, and talks depend on the company defending the legal action; the legal proceedings section moved to a later page, and any other changes are not visible in the excerpt.

Discuss in chat

17 Sept 2007business combination● Neutral

First amendment to the Anguilla move registration: the number of shares covered rises from 20,315,135 to 24,315,135, and the stock price quoted fell to $0.32 (September 7, 2007). It adds that the company has completed a development plan for the block and would try to restart talks with SOCAR if it wins the legal action against it.

Discuss in chat

21 Aug 2007director interest notice● Neutral

RHINO BIOTECH Ltd President and CEO Nicholas W Baxter bought 146,728 shares on the open market.

Discuss in chat

21 Aug 2007substantial holder notice● Neutral

Nicholas W. Baxter reported a RHINO BIOTECH Ltd shareholding of 3,073,364 shares (12.64% of votes) in a periodic institutional filing.

Discuss in chat

23 July 2007business combination● NeutralMajor

Eurasia Energy filed to register up to 20,315,135 shares in connection with a plan, approved by directors and majority shareholders on November 1, 2006, to move its legal home from Nevada to Anguilla. Existing shares stay one-for-one, and the filing says its ability to get the SOCAR MOU extended has been 'severely impaired' by a legal action against the company, which is the first mention of that dispute in this history; the stock closed at $0.45 on July 9, 2007.

Discuss in chat

19 Dec 2006material agreement termination▼ BadMajor

The December 2005 SOCAR memorandum of understanding expired because no agreement on the basic commercial terms of a production sharing agreement was signed by December 7, 2006. Management says it is still talking with SOCAR about extending the MOU and has finished its study and initial development plan for the block; no extension is reported.

Discuss in chat

11 Oct 2006other material event▼ BadMajor

Arawak Energy Corporation and its subsidiary Commonwealth Oil & Gas sued the company and CEO Nicholas Baxter in Edinburgh, alleging Baxter used confidential information from his time as their director to secure the SOCAR MOU. They seek US$17.2 million from Baxter, a declaration that the company holds the MOU in trust for them, and an accounting of profits up to US$100 million or equivalent damages. The company rejects the claims and says it has enough cash to fund its Azerbaijan work and the legal costs; this puts the MOU, the company's only disclosed asset, at risk.

Discuss in chat

20 Apr 2006director interest notice● Neutral

Roger Thomas became a RHINO BIOTECH Ltd director and company insider (initial ownership filing).

Discuss in chat

18 Apr 2006substantial holder notice● Neutral

Nicholas W. Baxter reported a RHINO BIOTECH Ltd shareholding of 3,000,000 shares (14.95% of votes) in a periodic institutional filing.

Discuss in chat

21 Mar 2006director interest notice● Neutral

RHINO BIOTECH Ltd President and CEO Velda King sold 20,000 shares at $2.50.

Discuss in chat

15 Feb 2006other material event▲ GoodMajor

Velda King resigned from the board effective Feb 15, 2006 (the filing says to devote time to other business interests and not over any disagreement). The company also closed a US$750,000 private placement of 250,000 units at US$3.00, each with one share and one warrant exercisable at US$4.00 until Feb 15, 2007. The company says the money will go partly to completing the development plan for the Azerbaijan block and the rest to working capital for 12-18 months; this adds new shares, so existing holders are diluted by 250,000 shares.

Discuss in chat

12 Jan 2006other material event▲ GoodMajor

The company began trading as Eurasia Energy Limited (symbol EUEN) on the OTC Bulletin Board on Jan 12, 2006, completing the name change approved in November. It states it is now pursuing oil and gas exploration and development, and discloses an MOU with SOCAR giving it the exclusive right to negotiate a production sharing agreement for a 600 sq km Caspian Sea block that includes the producing Alat-Deniz field and seven exploration structures. No agreement is signed yet; the MOU only gives negotiating rights.

Discuss in chat

22 Dec 2005substantial holder notice● Neutral

Nicholas W. Baxter reported a RHINO BIOTECH Ltd shareholding of 3,000,000 shares (14.95% of votes) in a periodic institutional filing.

Discuss in chat

19 Dec 2005material agreement▲ GoodMajor

The company (then filed as Pacific Alliance Ventures Ltd., renamed Eurasia Energy Limited after directors and holders of 54.81% of shares approved the change on November 28, 2005) signed a memorandum of understanding with Azerbaijan's state oil company SOCAR, effective December 7, 2005. It gives the company 12 months of exclusive rights to negotiate a production sharing agreement for a 600 sq km offshore Caspian block that includes the producing Alat-Deniz field and seven exploration structures; no agreement has yet been signed, and the filing says no shares or debt will be issued for the MOU. President and CEO Nicholas W. Baxter, who owns 15% of the shares, is credited with the opportunity.

Discuss in chat

2 Dec 2005other material event● Neutral

Nicholas Baxter, already a director since March 31, 2005, was appointed President and CEO on Nov 28, 2005, replacing Velda King, who stays on as a director and keeps running marketing and advertising. Holders of 54.81% of shares approved by written consent a change of the company's name from Pacific Alliance Ventures Ltd. to Eurasia Energy Limited, with preliminary proxy materials filed.

Discuss in chat

3 Nov 2005substantial holder notice● Neutral

Katrin Braun disclosed a new substantial RHINO BIOTECH Ltd shareholding (7.47% of votes).

Discuss in chat